title: Hepatosplenic T-cell lymphoma following infliximab therapy for Crohn's disease.
authors.forename: Daniel C
authors.initials: DC
authors.lastname: Burger
authors.forename: Timothy H J
authors.initials: TH
authors.lastname: Florin
mesh_terms: D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D000069285:Infliximab; D016399:Lymphoma, T-Cell / Q000209:etiology* / Q000276:immunology; D008297:Male; D015122:Mercaptopurine / Q000009:adverse effects; D055815:Young Adult
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab; D015122:Mercaptopurine